 Home > Medical News >

Medical Research Articles

FDA supports new treatment for Amarin's Vascepa capsule

 Time of Update: 2020-06-07

oil based gingivitis natural treatment organic fish oil clr active ingredient vitamins reduce cholesterol

, Amarin (http:// announced that the U.S FDA (http:// endocrine metabolism drug (http:// Advisory (http:// Committee (EMDAC) supports the company's development of Vascepa capsules as a new
FDA's U.S. accepts new drug application for cancer drug selumetinib and grants priority review

 Time of Update: 2020-06-07

citrobacter freundii treatment cell gene therapy cut stump treatment diesel algae treatment what stationary phase

recently, the http:// pharmaceutical giant AstraZeneca and partner Merck and Co announced that the of food and drugs (http:// ) Administration ( FDA (http:// had accepted and granted priori
Three companies jointly conduct clinical trials of antibody-linked drug enfortumab vedotin and Keytruda to treat urinary skin cancer

 Time of Update: 2020-06-07

anti parietal cell antibodies anti srp antibody phase 1 metabolism anti cancer living fuel cell companies

Recently, Seattle Genetics and Astellas announced a partnership agreement with Mercadon to jointly conduct a clinical trial (http:// for the treatment of pre-local advanced or metastatic urinary
NMPA approves Theiboantium drug Fycompa for treatment of seizures at age 12 and over

 Time of Update: 2020-06-07

viibryd drug new china covington photosensitive drug reaction librium drug savella drug

Recently, Eisai, a Japanese pharmaceutical company, announced that China's National Drug (http:// Regulatory Authority (NMPA) has approved a new generation of anti-epileptic drug Fycompa (perampa
FDA has granted IDH1 inhibitor Tibsovo (ivosidenib) breakthrough therapy designation

 Time of Update: 2020-06-07

pfizer gene therapy breakthrough therapy 1 cot 2 ivosidenib bard1 gene mutation

today, drug company Agios Pharmaceuticals (http:// announced that the U.S FDA (http:// has awarded the IDH1 inhibitor Tibsovo (ivosidenib) breakthrough therapy to treat recurrent/incurable bon
Roche Tecentriq combined with Avastin's combination therapy achieves positive results in the treatment of HCC3 trials

 Time of Update: 2020-06-07

abraxane chemotherapy berries immune system data strategy example red blood cell antibody positive inductive breast cancer

recently, Roche announced positive results in a combination of pD-L1 antibody Tecentriq (atezolizumab, atlizumab) combined with Avastin (bevacizumab, bevazumab) to treat patients who have not previo
Key Phase 2 trial of DS-8201, co-developed by AstraZeneca and Phase III, reaches the main research end

 Time of Update: 2020-06-07

monoclonal antibodies examples phase contrast ds 82 plasma phase iridite 14 2

today, AstraZeneca and Daiichi Sankyo company (http:// announced that the joint development of antibody conjugate drug (http:// (aDC) (fam-8201), in the treatment of HER2-positive metastatic b
Constellation CPI-0610 demonstrates good clinical activity in Phase 2 clinical trial called MANIFEST

 Time of Update: 2020-06-07

duloxetine drug class vetriscience pro line inflammatory intestinal disease 1 2 dichloroethane phase 1 trial

today, co stellation pharmaceutical (http:// announced that its selective BET inhibitor CPI-0610 demonstrated good clinical activity in the clinical trial (http:// called MANIFEST The trial w
Novo Nordisk Valley Gate Winter Double Insulin Injection (Novo and Jia ®) officially launched in China

 Time of Update: 2020-06-07

injection vial double stranded rna cefepime injection aranesp injection fasting lower blood sugar

recently, Novo Nordisk announced that the world's first soluble double insulin degudurd double insulin injection (Novo and Jia ®) has been officially launched in China to treat type 2 diabetes in ad
FDA approves gene tekolizumab in combination with chemotherapy to treat metastatic non-small cell lung cancer

 Time of Update: 2020-06-07

parainfluenza 3 treatment checkers 2 5 makeup cancer patients cas 9 line isopropyl alcohol use

today, Genentech, a member of the Roche group, announced that the Us FDA (http:// approved tecentriq (atezolizumab) and chemotherapy (Abraxane (a purple sequoia protein binding; nab-purple alcoho
And platinum medicine next-generation all-human anti-CTLA-4 antibody HBM4003 first patient has been successfully enrolled in the group medication

 Time of Update: 2020-06-07

platinum compounds interesting animals research mast cell tumor human parietal cell antibody ibuprofen half life

recently, and platinum Medicine sin pharmaceutical (http:// announced that its new generation of all-human anti-CTLA-4 antibody HBM4003 has launched the first global clinical trial (http:// fo
Gritstone's two vaccines Granite and Slate get positive safety data in Phase 1 clinical trials

 Time of Update: 2020-06-07

hiv clinical trials panc 1 cells peptide new host 1 non stick safe

recently, Gritstone (http:// announced that its two vaccines, Granite and Slate, based on new tumor antigens, were developed to obtain positive iogenic activity and safety data in the phase 1 cli
Methafluoluothantinib listing application approved for treatment of chronic adult patients with chronic myeloid leukemia

 Time of Update: 2020-06-07

bubble drug abilify drug pink new drug xarelto drug class mde drug

recently, it was reported that the listing application for methionate flumartinibinib (product name: Haussen-Fu) was approved for the treatment of chronic myeloid leukemia (Ph-CML) chronic adult pat
Scientists develop a new drug candidate for breast cancer

 Time of Update: 2020-06-07

stem cells used vitamin b9 supplements anti vitamin anti inflammatory breast cancer pill

recently, scientists have discovered a new drug (http:// that could starve or suffocate cancer stem cells, paving the way for new treatments for breast cancer patients The study at the Universi
U.S. FDA grants Kiniksa's rilonacept breakthrough therapy

 Time of Update: 2020-06-07

rapid acting insulin 1 2 ghz omega alpha beta natural drugs herpes 1 2

today, Kiniksa Pharmaceuticals (http:// announced that the U.S FDA (http:// granted its determination to treat recurrent enticatis (RP) in the il-1 signaling pathway inhibitor rilonacept Abou
Gilead announces new clinical research data on hepatitis B functional cure new drug GS-9688

 Time of Update: 2020-06-07

antigen receptor benzodiazepine receptor agonist hbsag treatment small data gs pool

recently, Gilead, the giant of pharmaceutical (http:// released new clinical research data on the functional cure the new drug (http:// Gs-9688( selgantolimod) About GS-9688 GS-9688 is an or
FDA approves Noor and Nordmen winter insulin injection Fiasp100u/mL label expansion

 Time of Update: 2020-06-07

2 4 label winter diesel available eldoncard blood type test vitamin blood panel 1 cot 2

recently, Novo Nordisk announced that it has approved the expansion of its fiasp100u/mL label the fda's (http:// The label extension allows Fiasp to be given through an insulin pump to improve b
Noten Jianhua BTK inhibitor Obitini ICP-022 new drug listing application accepted

 Time of Update: 2020-06-07

global clinical trials phase 1 metabolism small safety glasses cyclobenzaprine drug test strip drug test

recently, it has been reported that the http:// high-selective and irreversible small molecule Bruton tyrosine kinase (BTK) inhibitor Obitini ICP-022 developed by Innocare has been accepted for the
The phase 3 trial of Takeda protease inhibitor Ninlaro (ixazomib) reaches the main end of the trial

 Time of Update: 2020-06-07

medical ketamine clinical trials antipsychotic drugs used treat protease phentermine fda approved

today, Takeda (http:// announced that its protease inhibitor Ninlaro (ixazomib) as a first-line maintenance therapy, in the treatment of adult patients with multiple myeloma (MM) without stem cel
FDA grants Brynering Ingeheim's breakthrough drug

 Time of Update: 2020-06-07

nintedanib tergitol 15 9 drug disease interaction small molecule inhibitors day rape drug

The u.S food and drug (http:// Administration ( FDA (http:// has granted its oral small molecule tyrosine kinase inhibitor, Oftedanib, Nidanibu, a breakthrough drug qualification (BTD), the ge

Go to Page

Medical Research Articles

FDA supports new treatment for Amarin's Vascepa capsule

FDA's U.S. accepts new drug application for cancer drug selumetinib and grants priority review

Three companies jointly conduct clinical trials of antibody-linked drug enfortumab vedotin and Keytruda to treat urinary skin cancer

NMPA approves Theiboantium drug Fycompa for treatment of seizures at age 12 and over

FDA has granted IDH1 inhibitor Tibsovo (ivosidenib) breakthrough therapy designation

Roche Tecentriq combined with Avastin's combination therapy achieves positive results in the treatment of HCC3 trials

Key Phase 2 trial of DS-8201, co-developed by AstraZeneca and Phase III, reaches the main research end

Constellation CPI-0610 demonstrates good clinical activity in Phase 2 clinical trial called MANIFEST

Novo Nordisk Valley Gate Winter Double Insulin Injection (Novo and Jia ®) officially launched in China

FDA approves gene tekolizumab in combination with chemotherapy to treat metastatic non-small cell lung cancer

And platinum medicine next-generation all-human anti-CTLA-4 antibody HBM4003 first patient has been successfully enrolled in the group medication

Gritstone's two vaccines Granite and Slate get positive safety data in Phase 1 clinical trials

Methafluoluothantinib listing application approved for treatment of chronic adult patients with chronic myeloid leukemia

Scientists develop a new drug candidate for breast cancer

U.S. FDA grants Kiniksa's rilonacept breakthrough therapy

Gilead announces new clinical research data on hepatitis B functional cure new drug GS-9688

FDA approves Noor and Nordmen winter insulin injection Fiasp100u/mL label expansion

Noten Jianhua BTK inhibitor Obitini ICP-022 new drug listing application accepted

The phase 3 trial of Takeda protease inhibitor Ninlaro (ixazomib) reaches the main end of the trial

FDA grants Brynering Ingeheim's breakthrough drug